Latest Insider Transactions at Eagle Pharmaceuticals, Inc. (EGRX)
This section provides a real-time view of insider transactions for Eagle Pharmaceuticals, Inc. (EGRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EAGLE PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EAGLE PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2024
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,119
-0.46%
|
$12,714
$6.27 P/Share
|
|
Feb 27
2024
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,589
-3.21%
|
$9,534
$6.44 P/Share
|
|
Feb 27
2024
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+7.12%
|
-
|
|
Feb 27
2024
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,154
-0.68%
|
$18,924
$6.44 P/Share
|
|
Feb 27
2024
|
Scott Tarriff |
BUY
Grant, award, or other acquisition
|
Direct |
12,950
+2.7%
|
-
|
|
Feb 02
2024
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
934
-2.0%
|
$4,670
$5.85 P/Share
|
|
Jan 05
2024
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
4,322
-0.79%
|
$21,610
$5.13 P/Share
|
|
Jan 05
2024
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.55%
|
$3,675
$5.13 P/Share
|
|
Dec 18
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
452
-0.94%
|
$1,808
$4.76 P/Share
|
|
Nov 02
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,694
-1.92%
|
$139,022
$13.87 P/Share
|
|
Nov 01
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,925
-1.93%
|
$142,025
$13.82 P/Share
|
|
Oct 27
2023
|
Michael Graves Interim Executive Chair & PEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,360
+47.46%
|
$37,440
$4.94 P/Share
|
|
Oct 03
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,734
-0.93%
|
$150,276
$14.76 P/Share
|
|
Oct 02
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
9,511
-1.62%
|
$142,665
$15.23 P/Share
|
|
May 16
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
15,000
-2.49%
|
$285,000
$19.98 P/Share
|
|
May 15
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
15,000
-0.47%
|
$315,000
$21.29 P/Share
|
|
May 12
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
15,000
-0.46%
|
$300,000
$20.06 P/Share
|
|
May 11
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
15,000
-0.91%
|
$300,000
$20.71 P/Share
|
|
Mar 01
2023
|
Scott Tarriff |
BUY
Grant, award, or other acquisition
|
Direct |
70,900
+4.14%
|
-
|
|
Mar 01
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,500
+27.87%
|
-
|
|
Feb 28
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-0.2%
|
$87,164
$28.0 P/Share
|
|
Feb 28
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
718
-2.39%
|
$20,104
$28.0 P/Share
|
|
Feb 02
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
785
-2.54%
|
$26,690
$34.09 P/Share
|
|
Jan 30
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
601
-1.91%
|
$19,833
$33.21 P/Share
|
|
Jan 23
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,732
-0.24%
|
$123,156
$33.64 P/Share
|
|
Jan 05
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,827
-0.24%
|
$110,983
$29.26 P/Share
|
|
Jan 05
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-2.28%
|
$21,286
$29.26 P/Share
|
|
Dec 19
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
461
-1.41%
|
$13,830
$30.03 P/Share
|
|
Sep 06
2022
|
Richard A. Edlin Director |
SELL
Open market or private sale
|
Direct |
6,800
-23.13%
|
$204,000
$30.99 P/Share
|
|
Feb 28
2022
|
Scott Tarriff |
BUY
Grant, award, or other acquisition
|
Direct |
34,800
+2.16%
|
-
|
|
Feb 28
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+19.67%
|
-
|
|
Feb 28
2022
|
Michael Shawn Moran EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,400
+24.46%
|
-
|
|
Feb 02
2022
|
Michael Shawn Moran EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-3.3%
|
$33,390
$45.03 P/Share
|
|
Feb 02
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
805
-3.16%
|
$36,225
$45.03 P/Share
|
|
Jan 31
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-2.4%
|
$28,170
$45.94 P/Share
|
|
Jan 31
2022
|
Michael Shawn Moran EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-0.93%
|
$9,450
$45.94 P/Share
|
|
Jan 07
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-1.0%
|
$13,150
$50.63 P/Share
|
|
Jan 07
2022
|
Michael Shawn Moran EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.4%
|
$4,500
$50.63 P/Share
|
|
Jan 05
2022
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-2.72%
|
$36,900
$50.69 P/Share
|
|
Jan 05
2022
|
Michael Shawn Moran EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,511
-6.23%
|
$75,550
$50.69 P/Share
|
|
Dec 20
2021
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-1.69%
|
$25,685
$55.42 P/Share
|
|
Apr 08
2021
|
Steven B Ratoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,020
+8.59%
|
$49,140
$7.33 P/Share
|
|
Apr 01
2021
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
16,278
-1.04%
|
$667,398
$41.87 P/Share
|
|
Apr 01
2021
|
Scott Tarriff |
BUY
Exercise of conversion of derivative security
|
Direct |
31,201
+1.96%
|
$249,608
$8.78 P/Share
|
|
Feb 23
2021
|
Scott Tarriff |
SELL
Bona fide gift
|
Direct |
16,340
-1.06%
|
-
|
|
Feb 02
2021
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,900
+24.41%
|
-
|
|
Feb 02
2021
|
Judith Ng Cashin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
Feb 02
2021
|
David Pernock Pres & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,700
+15.08%
|
-
|
|
Jan 29
2021
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-3.3%
|
$29,302
$46.67 P/Share
|
|
Jan 23
2021
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
4,631
-0.3%
|
$217,657
$47.7 P/Share
|